Remove Contract Manufacturing Remove Genome Remove Licensing Remove Life Science
article thumbnail

Athersys Announces Three Appointments to Board of Directors

The Pharma Data

She chairs the board of directors of Sellas Life Sciences, a publicly traded biotechnology company, chairs its nominations & governance committee, and is a member of its audit, compensation and finance committees. She currently serves as a non-executive director on the board of Genfit, S.A.,

article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. Research into genomic medicines is only at its infancy. Workforce . But challenges remain.